Back

mr. K.L. (Gert) Janki

mr. K.L. (Gert) Janki

Associate Professor

Show full profile

Research Output (75)

A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE)

van Goor I W J M, Daamen L A, Besselink M G, Bruynzeel A M E, Busch O R, Cirkel G A, Groot Koerkamp B, Haj Mohammed N, Heerkens H D, van Laarhoven H W M, Meijer G J, Nuyttens J, van Santvoort H C, van Tienhoven G, Verkooijen H M, Wilmink J W, Molenaar I Q, Intven M P W, 28 Oct 2022, In: Trials. 23

Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer:An R-IDEAL stage 1b/2a evaluation of technical innovation

Boekhoff M. R., Bouwmans R., Doornaert P. A.H., Intven M. P.W., Lagendijk J. J.W., van Lier A. L.H.M.W., Rasing M. J.A., van de Ven S., Meijer G. J., Mook S. May 2022, In: Clinical and translational radiation oncology. 34 , p. 82-89 8 p.

Detecting Interval Distant Metastases With 18F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer

Kroese Tiuri E, Ruurda Jelle P, Bakker Anne S, Jairam Jasvir, Mook Stella, van der Horst Sylvia, Meijer Gert J, Haj Mohammad Nadia, van Rossum Peter S N, van Hillegersberg Richard 5 Apr 2022, In: Clinical Nuclear Medicine. 47 , p. 496-502 7 p.

Intrafraction pancreatic tumor motion patterns during ungated magnetic resonance guided radiotherapy with an abdominal corset

Grimbergen Guus, Eijkelenkamp Hidde, Heerkens Hanne D., Raaymakers Bas W., Intven Martijn P.W., Meijer Gert J. Jan 2022, In: Physics and Imaging in Radiation Oncology. 21 , p. 1-5 5 p.

An in-silico assessment of the dosimetric benefits of MR-guided radiotherapy for esophageal cancer patients

Boekhoff Mick, Defize Ingmar, Borggreve Alicia, van Hillegersberg Richard, Kotte Alexis, Lagendijk Jan, van Lier Astrid, Ruurda Jelle, Takahashi Noriyoshi, Mook Stella, Meijer Gert Sep 2021, In: Radiotherapy and Oncology. 162 , p. 76-84 9 p.

PTV margin assessment for an online adaptive MR-guided dose-escalation strategy in rectal cancer

Eijkelenkamp H., Boekhoff M., Verweij M., Peters F., Meijer G., Intven M. Aug 2021, In: Radiotherapy and Oncology. 161 , p. S489-S489

Online adaptive MR-guided SBRT for unresectable upper abdominal malignancies using a 1.5T MR-linac

Daamen L., van Otterloo S. de Mol, van Goor I., Eijkelenkamp H., Erickson B., Hall W., Heerkens H., Meijer G., Molenaar Q., van Santvoort H., Verkooijen L., Intven M. Aug 2021, In: Radiotherapy and Oncology. 161 , p. S1008-S1009

Planning target volume margin assessment for online adaptive MR-guided dose-escalation in rectal cancer on a 1.5 T MR-Linac

Eijkelenkamp Hidde, Boekhoff Mick R, Verweij Maaike E, Peters Femke P, Meijer Gert J, Intven Martijn P W 17 Jul 2021, In: Radiotherapy & Oncology. 162 , p. 150-155 6 p.

CTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis

Boekhoff M R, Defize I L, Borggreve A S, van Hillegersberg R, Kotte A N T J, Lagendijk J J W, van Lier A L H M W, Ruurda J P, Takahashi N, Mook S, Meijer G J 14 May 2021, In: Radiotherapy & Oncology. 161 , p. 16-22 7 p.

Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions

Hall William A, Small Christina, Paulson Eric, Koay Eugene J, Crane Christopher, Intven Martijn, Daamen Lois A, Meijer Gert J, Heerkens Hanne D, Bassetti Michael, Rosenberg Stephen A, Aitken Katharine, Myrehaug Sten, Dawson Laura A, Lee Percy, Gani Cihan, Chuong Michael David, Parikh Parag J, Erickson Beth A 11 May 2021, In: Frontiers in oncology. 11 9 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not